Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2015
  • 2014
  • 2013
  • 2011

Author

  • Charles Vogel
2 Scopus citations

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

Mackey, J. R., Martin, M., Pienkowski, T., Rolski, J., Guastalla, J. P., Sami, A., Glaspy, J., Juhos, E., Wardley, A., Fornander, T., Hainsworth, J., Coleman, R., Modiano, M. R., Vinholes, J., Pinter, T., Rodríguez-Lescure, Á., Colwell, B., Whitlock, P., Provencher, L., Laing, K. & 10 others, Walde, D., Price, C., Hugh, J. C., Childs, B. H., Bassi, K., Lindsay, M. A., Wilson, V., Rupin, M., Houé, V. & Vogel, C., Jan 1 2013, In : The Lancet Oncology. 14, 1, p. 72-80 9 p.

Research output: Contribution to journalArticle

131 Scopus citations

A phase II tolerability trial of neoadjuvant docetaxel with carboplatin and capecitabine in locally advanced breast cancer

Mani, A., Franco, S. X., Wang, G., Abramson, N., Schwartzberg, L. S., Jakub, J., Tan-Chiu, E., Schwartz, M. A., Frankel, C., Krill-Jackson, E. A., Stein, A., Perez, A. T. & Vogel, C. L., May 2011, In : Community Oncology. 8, 5, p. 209-215 7 p.

Research output: Contribution to journalArticle

1 Scopus citations

A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancer

Ambros, T., Zeichner, S. B., Zaravinos, J., Montero, A. J., Ahn, E. R., Aruna, M., Kronish, L., Mahtani, R. L. & Vogel, C. L., Jul 2014, In : Breast cancer research and treatment. 146, 1, p. 7-14 8 p.

Research output: Contribution to journalReview article

9 Scopus citations
1 Scopus citations

Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer

Kaufman, P. A., Bloom, K. J., Burris, H., Gralow, J. R., Mayer, M., Pegram, M., Rugo, H. S., Swain, S. M., Yardley, D. A., Chau, M., Lalla, D., Yoo, B., Brammer, M. G. & Vogel, C. L., Sep 1 2014, In : Cancer. 120, 17, p. 2657-2664 8 p.

Research output: Contribution to journalArticle

29 Scopus citations

Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG)

Kittaneh, M., Badve, S., Caldera, H., Coleman, R., Goetz, M. P., Mahtani, R., Mamounas, E., Kalinsky, K., Lower, E., Pegram, M., Press, M. F., Rugo, H. S., Schwartzberg, L., Traina, T. & Vogel, C., Jun 2020, In : Clinical breast cancer. 20, 3, p. 183-193 11 p.

Research output: Contribution to journalReview article

Open Access
1 Scopus citations

Defining the survival benchmark for breast cancer patients with systemic relapse

Zeichner, S. B., Ambros, T., Zaravinos, J., Montero, A. J., Mahtani, R. L., Ahn, E. R., Mani, A., Markward, N. J. & Vogel, C. L., Feb 12 2015, In : Breast Cancer: Basic and Clinical Research. 9, p. 9-17 9 p.

Research output: Contribution to journalArticle

10 Scopus citations

Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG)

Abraham, J., Caldera, H., Coleman, R., Elias, A., Goetz, M. P., Kittaneh, M., Lower, E., Mahtani, R., Terry Mamounas, E., Pegram, M., Rugo, H., Schwartzberg, L., Traina, T. & Vogel, C., May 1 2018, In : Breast cancer research and treatment. 169, 1

Research output: Contribution to journalReview article

3 Scopus citations

Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: A randomized Phase II study comparing the incidence of peripheral neuropathy

Vahdat, L. T., Garcia, A. A., Vogel, C., Pellegrino, C., Lindquist, D. L., Iannotti, N., Gopalakrishna, P. & Sparano, J. A., Jul 2013, In : Breast cancer research and treatment. 140, 2, p. 341-351 11 p.

Research output: Contribution to journalArticle

39 Scopus citations

Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: A pooled analysis

Pajares, B., Pollán, M., Martín, M., Mackey, J. R., Lluch, A., Gavila, J., Vogel, C., Ruiz-Borrego, M., Calvo, L., Pienkowski, T., Rodríguez-Lescure, Á., Seguí, M. A., Tredan, O., Antón, A., Ramos, M., Cámara, M. D. C., Rodríguez-Martín, C., Carrasco, E. & Alba, E., Nov 6 2013, In : Breast Cancer Research. 15, 6, R105.

Research output: Contribution to journalArticle

33 Scopus citations

Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2) -positive breast cancer after prior HER2-directed therapy

Burris, H. A., Rugo, H. S., Vukelja, S. J., Vogel, C. L., Borson, R. A., Limentani, S., Tan-Chiu, E., Krop, I. E., Michaelson, R. A., Girish, S., Amler, L., Zheng, M., Chu, Y. W., Klencke, B. & O'Shaughnessy, J. A., Feb 1 2011, In : Journal of Clinical Oncology. 29, 4, p. 398-405 8 p.

Research output: Contribution to journalArticle

476 Scopus citations

Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literature

Zeichner, S. B., Herna, S., Mani, A., Ambros, T., Montero, A. J., Mahtani, R., Ahn, E. R. & Vogel, C., Sep 10 2015, In : Breast Cancer Research and Treatment. 153, 3, p. 617-624 8 p.

Research output: Contribution to journalArticle

21 Scopus citations

Toremifene for breast cancer: A review of 20 years of data

Vogel, C. L., Johnston, M. A., Capers, C. & Braccia, D., Feb 2014, In : Clinical breast cancer. 14, 1, p. 1-9 9 p.

Research output: Contribution to journalReview article

33 Scopus citations
13 Scopus citations
3 Scopus citations